#EA23: Outcome in Patients With Postponed Elective Surgery During COVID-19 The 30-day outcome findings in patients undergoing postponed elective surgery during the COVID-19 pandemic (TRACE II) were presented at a poster session at Euroanaesthesia 2023. The COVID-19 pandemic significantly affected the ability to perform elective surgeries worldwide. To understand the consequences of delayed surgery, the TRACE II study investigates the impact on patients' preopera...

Original Investigation  August 16, 2023 Outcomes Following Lung Transplant for COVID-19–Related Complications in the US Panagiotis Tasoudis, Leonard J. Lobo, Raymond D. Coakley, et al JAMA Surg. Published online August 16, 2023. doi:10.1001/jamasurg.2023.3489 Key Points Question  What are the outcomes following lung transplant for COVID-19–related complications? Findings  In this co...

Invited Commentary  May 17, 2023 Long-Term Impact of Trauma in Twins Timothy A. Pritts JAMA Surg. 2023;158(7):746. doi:10.1001/jamasurg.2023.1568 Trauma remains a leading cause of death and disability worldwide. For those who survive a severe traumatic injury, the personal costs are subjectively substantial but may be difficult to objectively quantify. Previous studies attempting to do this have determined that many factors are associated with long-ter...

#EA23: ESAIC Guidelines for Use of Cardiac Biomarkers in Perioperative Risk Evaluation The ESAIC focused guidelines on cardiac biomarkers were presented at Euroanaesthesia 2023 in Glasgow this week. There has been growing interest in utilising cardiac biomarkers in non-cardiac surgery patients. These biomarkers may be used with three separate aims. Firstly, they are used for prognosis, helping to determine how elevated levels of biomarkers affect the risk of spe...

ORIGINAL ARTICLE Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons Lisa L. Barnes, Klodian Dhana, Xiaoran Liu, et al N Engl J Med 2023; 389:602-611DOI: 10.1056/NEJMoa2302368 Abstract BACKGROUND Findings from observational studies suggest that dietary patterns may offer protective benefits against cognitive decline, but data from clinical trials are limited. The Mediterranean–DASH Intervention for Neurodegenerative Delay, known a...

Invited Commentary  May 24, 2023 Local Delivery of Antibiotics—Applications in Cutaneous Surgery and Beyond Amanda R. Sergesketter, Scott T. Hollenbeck JAMA Surg. 2023;158(7):727. doi:10.1001/jamasurg.2023.1215 Across surgical subspecialties, surgical site infections (SSIs) represent a prevalent and costly problem to patients and health care systems, affecting 0.5% to 3.0% of surgical patients and resulting in costs ranging from $3.5 billion to $10 bil...

Original Investigation  August 15, 2023 Prenatal Intravenous Magnesium at 30-34 Weeks’ Gestation and Neurodevelopmental Outcomes in Offspring: The MAGENTA Randomized Clinical Trial Caroline A. Crowther, Pat Ashwood, Philippa F. Middleton, et al JAMA. 2023;330(7):603-614. doi:10.1001/jama.2023.12357 Key Points Question  Does intravenous magnesium sulfate for pregnant individuals at risk of delive...

#EA23 - ESAIC Glasgow Declaration on Anaesthesiology and Intensive Care The European Society of Anaesthesiology and Intensive Care (ESAIC) Glasgow Declaration on Anaesthesiology and Intensive Care (EGD) was officially signed today during the inauguration of the Exhibition at #EA23 the Dear Green Place. This marks a monumental moment in healthcare history.  The European Union (EU) is dedicated to addressing climate change. The European Green Deal initiative ...

Original Investigation  July 17, 2023 Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial John R. Sims, Jennifer A. Zimmer, Cynthia D. Evans, et al JAMA. 2023;330(6):512-527. doi:10.1001/jama.2023.13239 Key Points Question  Does donanemab, a monoclonal antibody designed to clear brain amyloid plaque, provide clinical benefit in early symptomatic Alzheimer...

Original Investigation  August 8, 2023 Sugar-Sweetened and Artificially Sweetened Beverages and Risk of Liver Cancer and Chronic Liver Disease Mortality Longgang Zhao, Xinyuan Zhang, Mace Coday, et al JAMA. 2023;330(6):537-546. doi:10.1001/jama.2023.12618 Key Points Question  Is greater intake of sugar-sweetened beverages associated with greater risk of liver cancer or chronic liver disease mort...